LOADING
Comparing Pfizer Inc (PFE) and Nike Inc (NKE) across the Health Care and Consumer Discretionary sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | PFE | NKE |
|---|---|---|
| Price | $27.72 | $36.80 |
| Change Today | +0.25% | +0.49% |
| Market Cap | $158.0B | $54.6B |
| P/E Ratio | 36.5 | 17.5 |
| Forward P/E | 9.5 | 21.3 |
| PEG Ratio | 12.65 | 1.42 |
| EPS | $0.76 | $2.10 |
| Revenue Growth (YoY) | 2.6% | -1.1% |
| Profit Margin | 6.8% | 6.7% |
| Return on Equity | 5.0% | 22.1% |
| Dividend Yield | 6.22% | 4.45% |
| Beta | 0.30 | 1.11 |
| 52-Week High | $29.21 | $74.51 |
| 52-Week Low | $22.03 | $36.55 |
| Volume | 25.6M | 20.0M |
Pfizer Inc is the larger company by market capitalization. Nike Inc trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Pfizer Inc offers a higher dividend yield for income investors. Pfizer Inc has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.